Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-10-25
2000-10-24
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31335
Patent
active
061368466
ABSTRACT:
A pharmaceutical formulation is provided for delivering paclitaxel in vivo comprising: water and micelles comprising paclitaxel and a pharmaceutically-acceptable, water-miscible solubilizer forming the micelles, the solubilizer selected from the group consisting of solubilizers having the general structures
REFERENCES:
patent: 5504102 (1996-04-01), Agharkar et al.
patent: 5670537 (1997-09-01), Canetta et al.
patent: 5681846 (1997-10-01), Trissel
patent: 5922754 (1999-07-01), Burchett et al.
patent: 5925776 (1999-07-01), Nikolayev et al.
patent: 6017948 (2000-01-01), Rubinfeld et al.
patent: 6046230 (2000-04-01), Chung et al.
Constantinides, Panayiotis P. et al., "Formulation Development and Antitumor Activity of a Filter-Sterilizable Emulsion of Paclitaxel", Pharmaceutical Research, vol. 17, No. 2 (2000), pp. 175-182.
Gore Ashok Y.
Joshi Rajashree
Rubinfeld Joseph
Shrotriya Rajesh
Reamer James H.
Supergen, Inc.
Weitz David J.
LandOfFree
Formulation for paclitaxel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulation for paclitaxel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for paclitaxel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1964585